Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
View ORCID ProfileThiago Cerqueira-Silva, Jason R. Andrews, Viviane S. Boaventura, Otavio T. Ranzani, Vinicius de Araújo Oliveira, Enny S Paixão, Juracy Bertoldo Júnior, Tales Mota Machado, Matt D.T. Hitchings, Murilo Dorion, Margaret L Lind, Gerson O. Penna, Derek A.T. Cummings, Natalie E Dean, Guilherme Loureiro Werneck, Neil Pearce, Mauricio L. Barreto, View ORCID ProfileAlbert I. Ko, View ORCID ProfileJulio Croda, Manoel Barral-Netto
doi: https://doi.org/10.1101/2021.12.21.21268058
Thiago Cerqueira-Silva
1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
2Universidade Federal da Bahia, Salvador, BA, Brazil
Jason R. Andrews
3Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA,USA
Viviane S. Boaventura
1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
2Universidade Federal da Bahia, Salvador, BA, Brazil
Otavio T. Ranzani
4Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
5Pulmonary Division, Heart Institute, Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil
Vinicius de Araújo Oliveira
1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
2Universidade Federal da Bahia, Salvador, BA, Brazil
6Center for Data and Knowledge Integration for Health - Fiocruz, Salvador, BA, Brazil
Enny S Paixão
7London School of Hygiene and Tropical Medicine, London, United Kingdom
Juracy Bertoldo Júnior
2Universidade Federal da Bahia, Salvador, BA, Brazil
6Center for Data and Knowledge Integration for Health - Fiocruz, Salvador, BA, Brazil
Tales Mota Machado
8Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
Matt D.T. Hitchings
9Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA
Murilo Dorion
10Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Heaven, CT, USA
Margaret L Lind
10Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Heaven, CT, USA
Gerson O. Penna
11Núcleo de Medicina Tropical, Universidade de Brasília, Brasília, DF, Brazil
12Escola Fiocruz de Governo, Fiocruz Brasília. Brasília, DF, Brazil
Derek A.T. Cummings
13Department of Biology, University of Florida, Gainesville, FL, USA
14Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Natalie E Dean
15Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University
Guilherme Loureiro Werneck
16Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
Neil Pearce
7London School of Hygiene and Tropical Medicine, London, United Kingdom
Mauricio L. Barreto
2Universidade Federal da Bahia, Salvador, BA, Brazil
6Center for Data and Knowledge Integration for Health - Fiocruz, Salvador, BA, Brazil
Albert I. Ko
1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
10Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Heaven, CT, USA
Julio Croda
10Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Heaven, CT, USA
17Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
18Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
Manoel Barral-Netto
1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
2Universidade Federal da Bahia, Salvador, BA, Brazil
6Center for Data and Knowledge Integration for Health - Fiocruz, Salvador, BA, Brazil
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted December 27, 2021.
Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
Thiago Cerqueira-Silva, Jason R. Andrews, Viviane S. Boaventura, Otavio T. Ranzani, Vinicius de Araújo Oliveira, Enny S Paixão, Juracy Bertoldo Júnior, Tales Mota Machado, Matt D.T. Hitchings, Murilo Dorion, Margaret L Lind, Gerson O. Penna, Derek A.T. Cummings, Natalie E Dean, Guilherme Loureiro Werneck, Neil Pearce, Mauricio L. Barreto, Albert I. Ko, Julio Croda, Manoel Barral-Netto
medRxiv 2021.12.21.21268058; doi: https://doi.org/10.1101/2021.12.21.21268058
Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
Thiago Cerqueira-Silva, Jason R. Andrews, Viviane S. Boaventura, Otavio T. Ranzani, Vinicius de Araújo Oliveira, Enny S Paixão, Juracy Bertoldo Júnior, Tales Mota Machado, Matt D.T. Hitchings, Murilo Dorion, Margaret L Lind, Gerson O. Penna, Derek A.T. Cummings, Natalie E Dean, Guilherme Loureiro Werneck, Neil Pearce, Mauricio L. Barreto, Albert I. Ko, Julio Croda, Manoel Barral-Netto
medRxiv 2021.12.21.21268058; doi: https://doi.org/10.1101/2021.12.21.21268058
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)